About AGC Biologics
AGC Biologics is a Healthcare company based in Bothell (United States) founded in 2018 by Patricio E Massera. It provides contract development and manufacturing for biopharmaceuticals worldwide. It operates on a B2B and Enterprise Contracts model. AGC Biologics has completed 1 acquisition, including MolMed. Its chief executive is Patricio E Massera. AGC Biologics offers products and services including cGMP Manufacturing, Tech Transfer, Process Development, Analytical Development, and Fill and Finish. Its focus areas include Biotech, CDMO Services, Biologics Manufacturing and Advanced Therapies. Its competitors include Bionova Scientific, Avid Bioservices, Just Biotherapeutics, JHL Biotech and ProBioGen AG and 4 more; 4 of its 9 listed competitors have raised funding.
Company details
AGC Biologics offers comprehensive services as a CDMO, including tech transfer, process development, and cGMP manufacturing for protein-based biologics and advanced therapies. They operate globally with facilities in the US, Europe, and Asia, supporting clients in bringing new biopharmaceuticals to market through innovative platforms like viral vectors and cell therapy. Their focus includes quality systems and analytical development to ensure compliance and improve patient outcomes.
- Headquarters Bothell, United States
- Founders Patricio E Massera
- SectorsHealthcare
- Email••••••••
- Website agcbio.com
- Social LinkedIn X Facebook YouTube
- Legal Name Agc Biologics
- Investments & Acquisitions
Products & Services of AGC Biologics
AGC Biologics offers a comprehensive portfolio of products and services, including cGMP Manufacturing, Tech Transfer, Process Development, Analytical Development, and Fill and Finish.
Offers manufacturing for biologics under strict cGMP standards.
Facilitates technology transfer for biopharmaceutical projects.
Develops processes for upstream and downstream biologics production.
Provides analytical testing for product safety and purity.
Handles final packaging and finishing for drug products.
Apps and channels of AGC Biologics
its YouTube channel AGC Biologics has 99 subscribers and 30 videos.
Videos from AGC Biologics
The most watched videos on AGC Biologics's YouTube channel, AGC Biologics (99 subscribers). Click a video to play it here.
More on AGC Biologics.
People of AGC Biologics
365 people are tracked at AGC Biologics (108 in leadership, 257 in team).
| Name | Role | Group |
|---|---|---|
Patricio E Massera | Founder, CEO | Leadership |
Per Hommelgaard | Sr. Director Mammalian Manufacturing | Leadership |
Chris Cowley | Director Validation AGC Biologics Colorado | Leadership |
Jörg Ohl | Senior Director Business Development | Leadership |
Adam K. | Laboratory Site Head | Leadership |
Andrea Porchia | Senior Vice President, Business Development – Global Accounts | Leadership |
Annie Messmer | QA Training Partner | Leadership |
Christina Grauballe | Vice President, Global Supply Chain | Leadership |
Julia Kosan | Head Of Quality Control | Leadership |
Gitte Damgaard | Director QC Bioassay | Leadership |
Phil Weight | Director Of Engineering | Leadership |
Jeremy Howe | Director Of Manufacturing | Leadership |
Carrie Babcock | Senior Director | Leadership |
Vijay Patel | Director Of Quality Control | Leadership |
Ranjit Johal | Sr. Director People & Culture | Leadership |
Frederik Just Blangsted | Senior Partner, Talent Acquisition (us) | Leadership |
Jason Brady | Senior Director, Business Development | Leadership |
Bill Barrett | Director Of Business Development | Leadership |
Paul Dicandeloro | Senior Director Of Business Development; Cell And Gene Therapy CDMO | Leadership |
Kang Liu | Director, Business Development, China/singapore/india | Leadership |
345 more people are available in the full profile.
Complete people profiles for AGC Biologics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AGC Biologics
AGC Biologics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MolMed.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of gene and cell therapies for the treatment of cancer and rare diseases | molmed.com | Milano, Italy | 1996 | Jul 2020 | •••• |
Complete acquisition details for AGC Biologics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of AGC Biologics
2 dated milestones of AGC Biologics across 2 years, from founding to its latest funding, stage changes and deals.
- Founded AGC Biologics is founded.
- Acquisition Acquires MolMed.
Competitors of AGC Biologics
AGC Biologics has 9 listed competitors in our database, 4 of them funded. They include Bionova Scientific, Avid Bioservices, Just Biotherapeutics, JHL Biotech and ProBioGen AG, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bionovascientific.com | 2013 | Fremont, United States | $22M | 72 | Mammalian cell culture biologics are developed through contract research services. | |
| avidbio.com | 2002 | Orange, United States | – | 501 | Drug substance development, analytical, and compliance services are provided. | |
| justbiotherapeutics.com | 2014 | Seattle, United States | $123.51M | 79 | Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs | |
| jhlbiotech.com | 2012 | Hsinchu, Taiwan | $186.6M | – | Contract manufacturing solutions for biologics are provided to Asian companies. | |
| probiogen.de | 1994 | Berlin, Germany | – | – | Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars | |
| gallusbiopharma.com | 2010 | St. Louis, United States | – | – | Biologics CDMO specializing in mammalian cell line based manufacturing | |
| rentschler-biopharma.com | 1927 | Laupheim, Germany | – | 861 | Full-service CDMO for biopharmaceuticals | |
| mabplexinc.com | 2013 | Yantai, China | $130M | – | Biologics development and GMP manufacturing services are offered. | |
| polpharmabiologics.com | 2011 | Gdansk, Poland | – | – | Develops and manufactures biosimilar drugs and CDMO services for biotechnology applications. |
Detailed competitors of AGC Biologics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AGC Biologics
Websites that share an audience with AGC Biologics (agcbio.com).
Websites whose visitors overlap most with AGC Biologics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lyell.com | 100% | 14.3K | #3,232,661 | View details | |
| athira.com | 100% | 4.9K | #4,394,066 | View details | |
| cogentbio.com | 100% | 13.2K | #1,909,084 | View details | |
| swissamericancdmo.com | 100% | 1.6K | – | View details | |
| susupport.com | 94% | 45.6K | #727,525 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for AGC Biologics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as AGC Biologics (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Agc Biologics
Complete news archive for AGC Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AGC Biologics
AGC Biologics was founded in 2018.
AGC Biologics is headquartered in Bothell, United States. It is registered at Bothell, Washington, United States.
Patricio E Massera is the current CEO of AGC Biologics. They have also founded this company.
AGC Biologics offers comprehensive services as a CDMO, including tech transfer, process development, and cGMP manufacturing for protein-based biologics and advanced therapies. They operate globally with facilities in the US, Europe, and Asia, supporting clients in bringing new biopharmaceuticals to market through innovative platforms like viral vectors and cell therapy. Their focus includes quality systems and analytical development to ensure compliance and improve patient outcomes.
AGC Biologics's top competitors include Avid Bioservices, Bionova Scientific and Rentschler Biopharma.
AGC Biologics offers cGMP Manufacturing, Tech Transfer, Process Development, Analytical Development, and Fill and Finish.
AGC Biologics has made 1 acquisition, including MolMed.
AGC Biologics operates through Agc Biologics.